Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Perry

Showing results (201-210 of 1,379) with videos related to

Pageof 138
Sort By:
Ophthalmic Plastic and Reconstructive Surgery|January 3, 2025
Re: "Teprotumumab for the Treatment of Recalcitrant Thyroid Eye Disease"Julian D Perry, Catherine J Hwang
The Veterinary Record|March 7, 1992
Drug withdrawal periodsM D Perry, C L Watson
Current Opinion in Drug Discovery & Development|October 29, 2003
Molecular determinants of high-affinity drug binding to HERG channelsJohn S Mitcheson, Matthew D Perry
European Journal of Pharmacology|December 17, 1981
[3H]rauwolscine (alpha-yohimbine): a specific antagonist radioligand for brain alpha 2-adrenergic receptorsB D Perry, D C U'Prichard
American Journal of Ophthalmology|November 26, 2009
Rationale for radiotherapy in thyroid eye diseaseJulian D Perry, Steven E Feldon
Journal of Bacteriology|March 1, 1979
Accumulation of iron by yersiniaeR D Perry, R R Brubaker
Veterinary Parasitology|August 24, 1999
Improving the assessment of the economic impact of parasitic diseases and of their control in production animalsB D Perry, T F Randolph
Molecular Microbiology|May 1, 1993
Proteins essential for expression of the Hms+ phenotype of Yersinia pestisM L Pendrak, R D Perry
The Journal of Family Practice|January 1, 1979
Ophthalmia neonatorum due to Chlamydia trachomatis: a family problem?L D Perry, J H Brinser
Infection and Immunity|April 1, 1983
Vwa+ phenotype of Yersinia enterocoliticaR D Perry, R R Brubaker
Pageof 138

Showing results (201-210 of 1,379) with videos related to

Sort By:
Pageof 138
Ophthalmic Plastic and Reconstructive Surgery|January 3, 2025
Re: "Teprotumumab for the Treatment of Recalcitrant Thyroid Eye Disease"Julian D Perry, Catherine J Hwang
The Veterinary Record|March 7, 1992
Drug withdrawal periodsM D Perry, C L Watson
Current Opinion in Drug Discovery & Development|October 29, 2003
Molecular determinants of high-affinity drug binding to HERG channelsJohn S Mitcheson, Matthew D Perry
European Journal of Pharmacology|December 17, 1981
[3H]rauwolscine (alpha-yohimbine): a specific antagonist radioligand for brain alpha 2-adrenergic receptorsB D Perry, D C U'Prichard
American Journal of Ophthalmology|November 26, 2009
Rationale for radiotherapy in thyroid eye diseaseJulian D Perry, Steven E Feldon
Journal of Bacteriology|March 1, 1979
Accumulation of iron by yersiniaeR D Perry, R R Brubaker
Veterinary Parasitology|August 24, 1999
Improving the assessment of the economic impact of parasitic diseases and of their control in production animalsB D Perry, T F Randolph
Molecular Microbiology|May 1, 1993
Proteins essential for expression of the Hms+ phenotype of Yersinia pestisM L Pendrak, R D Perry
The Journal of Family Practice|January 1, 1979
Ophthalmia neonatorum due to Chlamydia trachomatis: a family problem?L D Perry, J H Brinser
Infection and Immunity|April 1, 1983
Vwa+ phenotype of Yersinia enterocoliticaR D Perry, R R Brubaker
Pageof 138